| Financial Year |
March 31 2023 |
| Monetary Funds |
57,060,413.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,234,033.42 |
| Advances to Suppliers |
48,103,086.49 |
| Other Receivables |
12,660,358.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,408,193.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,054,588.19 |
| Total Current Assets |
134,920,673.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
378,497.48 |
| Long-term Equity Investment |
12,017,128.83 |
| Investment Properties |
2,273,818.55 |
| Fixed Assetes |
356,595,682.05 |
| Under-construction Projects |
17,225,565.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
142,296,185.50 |
| R&D expenses |
2,654,228.84 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,703,489.86 |
| Deferred Income Tax Assets |
2,140,703.26 |
| Other Non-Current Assets |
85,400.00 |
| Sub-Total of Non-Current Assets |
570,986,938.25 |
| Total Assets |
705,907,611.68 |
| Short-Term Loans |
15,019,708.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
46,981,909.87 |
| Accounts Received In Advance |
174,000.00 |
| Employee Compensation Payable |
3,493,654.93 |
| Taxes Payable |
10,754,069.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,295,892.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
58,593,065.59 |
| Other Current Liabilities |
7,089,468.24 |
| Sub-Total of Current Liabilities |
236,131,694.70 |
| Long-term Loans |
140,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
49,917,964.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,182,100.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
198,530,568.65 |
| Total Liabilities |
434,662,263.35 |
| Paid-In Capital(Or Share Stock) |
348,990,000.00 |
| Capital Surplus |
305,717,774.21 |
| Surplus Reserve |
27,746,358.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-464,755,358.65 |
| Minority Stockholder's Interest |
8,120,134.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
263,125,213.70 |
| Owner's Equity（Stockholder's Equity） |
271,245,348.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
705,907,611.68 |
